Kweichow Moutai (600519) Report Interpretation

Overview

This earnings review assesses Kweichow Moutai's H126 miss, linking it to a weaker product mix, soft macro demand and the transition from distributor-led to direct sales. UBS expects near-term sentiment to weaken but retains its Buy rating and long-term thesis.

Core views

Kweichow Moutai reported H126 revenue of Rmb90,703mn, up 1.5% year on year, and net profit of Rmb44,517mn, down 2.0% year on year. Both figures were below consensus by 4% and 5%, respectively. Implied Q226 revenue was Rmb36,794mn, down 5.1% year on year, while implied net profit was Rmb17,274mn, down 6.9%. UBS attributes the miss primarily to weaker mix in both Moutai and series-liquor products—particularly non-standard Moutai products and Moutai 1935, which had traditionally benefited from distributor channels—alongside a weak Q226 macro backdrop also cited by peers. Profitability weakened with the mix. H126 gross profit margin including tax fell 2.3 percentage points year on year to 73.4%. The selling and distribution ratio declined 0.1 percentage point to 3.5%, and the G&A ratio also fell 0.1 percentage point, but these savings did not offset gross-margin pressure: operating profit margin declined 2.1 percentage points to 65.8%, while net profit margin fell 1.7 percentage points to 49.1%. Segment data underline the divergence. In H126, Moutai liquor generated Rmb77,724mn of revenue, up 2.8% year on year and representing 85.7% of sales, while series liquor generated Rmb12,934mn, down 6.0% and representing 14.3%. Their gross margins were 92.3% and 73.6%, down 1.6 and 4.0 percentage points, respectively. In Q226, Moutai liquor revenue fell 1% year on year to Rmb31,720mn and series-liquor revenue fell 25% to Rmb5,053mn, with the latter decline reinforcing the mix pressure identified by UBS. UBS views the channel shift as double-edged. In Q226, direct sales grew 34% year on year and represented 61% of sales revenue, versus 43% a year earlier; distributor sales fell 35% and represented 39%, versus 57%. iMoutai revenue surged 283% year on year to Rmb18,711mn, accounting for 51% of quarterly revenue. UBS argues that moving toward direct sales allows Moutai to capture consumer demand more directly and strengthen price control over core Feitian, which had two price increases during the year, in March and July. However, it also weakens distributors' ability to bundle high-margin non-standard Moutai and Moutai 1935, creating a near-term trade-off for product mix and profitability. UBS says its long-term thesis remains broadly unchanged because Moutai continues to reform its channel strategy and invest in digital infrastructure. It expects investors to react negatively to the weak H126 outcome in the near term and flags the online H126 results meeting on 21 August as the next opportunity for additional disclosure. UBS retains Buy, a Rmb1,617.00 12-month price target derived from DCF, and forecasts 20.5% price appreciation, 4.0% dividend yield and 24.5% forecast stock return versus a 6.8% market return assumption.

Analysis framework

UBS compares reported revenue and profit with consensus, derives the implied quarterly performance, then traces the miss through segment mix, margins and the shift between direct and distributor channels. It assesses the strategic benefits and costs of channel reform, retains its longer-term thesis, and values the shares using DCF.

Methodology notes

• Valuation methodsDCF (Discounted Cash Flow)

  DCF methodology

  UBS states that it derives the price target from a discounted cash flow methodology, which values the company using expected future cash flows discounted to a present value.

• Industry AnalysisVolume-price decomposition

  Product-mix, segment-margin and channel-sales analysis

  The report separates performance by Moutai liquor versus series liquor and by direct sales versus distributors to explain how mix and channel changes affected revenue growth and margins.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Kweichow Moutai (600519.SH)

  Primary covered company; UBS retains Buy following the H126 earnings review.

  Strengths

  Direct-sales reform, iMoutai growth, stronger consumer-demand capture and enhanced Feitian pricing control.

  Weaknesses

  Weaker product mix, declining series-liquor sales and lower margins in H126.

  Comparison

  Direct sales were 61% of Q226 revenue versus 43% in Q225, while distributor sales fell to 39% from 57%.

  Risks

  Macro weakness, capacity constraints, SOE structure, policy or regulatory changes, food-safety issues and strategic errors.

Key data

• H126 revenueRmb90,703mn; +1.5% YoY4% below consensus
• H126 net profitRmb44,517mn; -2.0% YoY5% below consensus
• Implied Q226 revenue / net profitRmb36,794mn / Rmb17,274mn-5.1% / -6.9% YoY
• H126 gross profit margin73.4%Down 2.3 percentage points YoY
• H126 operating profit margin / net profit margin65.8% / 49.1%Down 2.1 / 1.7 percentage points YoY
• Q226 direct sales / distributor sales+34% / -35% YoY61% / 39% of total revenue versus 43% / 57% in Q225
• iMoutai Q226 revenueRmb18,711mn; +283% YoY51% of quarterly revenue
• 12-month price targetRmb1,617.00DCF-derived

Impact & implications

UBS considers the earnings miss a near-term consequence of soft demand and channel-reform trade-offs rather than a change to its long-term thesis. Direct sales improve demand capture and Feitian pricing control, but the reduced distributor role may weigh on sales of higher-margin non-standard products and Moutai 1935.

Risks

• An economic downturn, including an acute property slowdown or falling property prices, could reduce demand for premium baijiu.
• Capacity constraints could restrain sales growth when demand is healthy.
• The SOE structure could curb growth potential.
• Government regulations or policies could negatively affect profitability.
• Food-safety issues could damage the Moutai brand image.
• Strategic errors are a stated risk.

What to watch

• The online H126 results meeting on 21 August, where UBS expects more information to be disclosed.
• The pace and profitability effects of the shift toward direct sales and iMoutai.
• Demand for non-standard Moutai products and Moutai 1935 amid the softer macro backdrop.